This year’s AACR annual meeting focused a great deal on the vindication of a very old idea: “seed and soil” model of metastasis. The idea that little seed cells from a tumor circulate through the body looking for fertile ground to implant into and grow a metastatic tumor. It’s only very recently that the technology has existed to provide a mechanism to detect these circulating seed cells. This knowledge has proven to be very important in predicting which patients will respond to different therapies.
This video is taken from the only FDA approved technology to detect these circulating tumor cells (CTCs). For any of you interested in what I do for a living, this is the clinical outcome of some technologies that I worked on at the “research use only” non-clinical level. Being able to tag cells with magnetic particles or beads and separate or enrich from that binding.
It’s five minutes long and includes a commercial in the middle, but I thought it was a cool “infographic” format. Very CSI!